Abstract:Streptococcus pneumoniae is an important human pathogen, being one of the most common causes of community-acquired pneumonia and otitis media. Antibiotic resistance in S. pneumoniae is an emerging problem, as it depletes our arsenal of effective drugs. In addition, persistence also contributes to the antibiotic crisis in many other pathogens, yet for S. pneumoniae, little is known about antibiotic-tolerant persisters and robust experimental means are lacking. Persister cells are phenotypic variants that exist as a subpopulation within a clonal culture. Being tolerant to lethal antibiotics, they underly the chronic nature of a variety of infections and even help in acquiring genetic resistance. In this study, we set out to identify and characterize persistence in S. pneumoniae. Specifically, we followed different strategies to overcome the self-limiting nature of S. pneumoniae as a confounding factor in the prolonged monitoring of antibiotic survival needed to study persistence. Under optimized conditions, we identified genuine persisters in various growth phases and for four relevant antibiotics through biphasic survival dynamics and heritability assays. Finally, we detected a high variety in antibiotic survival levels across a diverse collection of S. pneumoniae clinical isolates, which assumes that a high natural diversity in persistence is widely present in S. pneumoniae. Collectively, this proof of concept significantly progresses the understanding of the importance of antibiotic persistence in S. pneumoniae infections, which will set the stage for characterizing its relevance to clinical outcomes and advocates for increased attention to the phenotype in both fundamental and clinical research. IMPORTANCE S. pneumoniae is considered a serious threat by the Centers for Disease Control and Prevention because of rising antibiotic resistance. In addition to resistance, bacteria can also survive lethal antibiotic treatment by developing antibiotic tolerance, more specifically, antibiotic tolerance through persistence. This phenotypic variation seems omnipresent among bacterial life, is linked to therapy failure, and acts as a catalyst for resistance development. This study gives the first proof of the presence of persister cells in S. pneumoniae and shows a high variety in persistence levels among diverse strains, suggesting that persistence is a general trait in S. pneumoniae cultures. Our work advocates for higher interest for persistence in S. pneumoniae as a contributing factor for therapy failure and resistance development.

The research progress of antibiotic-tolerance persisters in microorganism community

Relationship and Conversion Between Persisters and Antimicrobial Resistant Bacteria

Molecular mechanism and application of emerging technologies in study of bacterial persisters

Bacterial persisters: molecular mechanisms and therapeutic development

The Formation Mechanism and Eradication Policy of Persisters

[Persisters and their effects on microbial biofilm tolerance: a review].

Proton motive force and antibiotic tolerance in bacteria

The progresses and perspectives of the control and eradication of persistent bacteria

Metabolic conservation by protein quality control in underlies the antibiotic tolerance

Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells

Dynamic protein aggregation regulates bacterial dormancy depth critical for antibiotic tolerance

The Physiological and Ecological Properties of Bacterial Persisters Discovered from Municipal Sewage Sludge and the Potential Risk

Environmental, mechanistic and evolutionary landscape of antibiotic persistence

Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance

Recent Advances in Bacterial Persistence Mechanisms

Molecular mechanisms of bacterial persistence and phenotypic antibiotic resistance.

Antibiotic Tolerance Indicative of Persistence Is Pervasive among Clinical Streptococcus pneumoniae Isolates and Shows Strong Condition Dependence

Antibiotic resistance and persistence—Implications for human health and treatment perspectives

Failure of antibiotic treatment in microbial populations

Genomic Insights into the Antibiotic Resistance Pattern of the Tetracycline-Degrading Bacterium, Arthrobacter Nicotianae OTC-16

Intracellular Staphylococcus aureus persisters upon antibiotic exposure